Abstract
Predicting genes and gene regions undergoing adaptive evolution is one of the most important aims of geneticists and of new emerging areas of investigation. As more genomes are being sequenced and computational tools to detect selection are being developed, the number of genes uncovered as being positively selected is overwhelming. Several statistical methods have been devised to test if specific amino acid regions have undergone adaptive mutations at some stage during the proteins evolution. Despite the sensitivity of these methods to detect selective constraints, they are still based on linear sequence alignments and therefore, examine only one dimension of the proteins evolution. Few methods have been designed to detect intra-molecular co-evolution between amino acid sites. However, no tests are performed to determine the adaptive value of these co-evolutionary events. Conclusions independently derived from both types of methods are ambiguous and seldom unequivocal, since evolution of protein sequences is most likely to be multifactorial. This review discusses and has briefly exposed the advantages and disadvantages of the many different methods and computational tools to detect adaptive evolution and co-evolution. Further, the potential that the combination of such methods has in providing more biologically meaningful results is highlighted.
Keywords: Adaptive evolution, coevolution, statistical methods, maximum likelihood, parsimony, covarion model
Current Bioinformatics
Title: Computational and Statistical Methods to Explore the Various Dimensions of Protein Evolution
Volume: 1 Issue: 2
Author(s): Mario A. Fares
Affiliation:
Keywords: Adaptive evolution, coevolution, statistical methods, maximum likelihood, parsimony, covarion model
Abstract: Predicting genes and gene regions undergoing adaptive evolution is one of the most important aims of geneticists and of new emerging areas of investigation. As more genomes are being sequenced and computational tools to detect selection are being developed, the number of genes uncovered as being positively selected is overwhelming. Several statistical methods have been devised to test if specific amino acid regions have undergone adaptive mutations at some stage during the proteins evolution. Despite the sensitivity of these methods to detect selective constraints, they are still based on linear sequence alignments and therefore, examine only one dimension of the proteins evolution. Few methods have been designed to detect intra-molecular co-evolution between amino acid sites. However, no tests are performed to determine the adaptive value of these co-evolutionary events. Conclusions independently derived from both types of methods are ambiguous and seldom unequivocal, since evolution of protein sequences is most likely to be multifactorial. This review discusses and has briefly exposed the advantages and disadvantages of the many different methods and computational tools to detect adaptive evolution and co-evolution. Further, the potential that the combination of such methods has in providing more biologically meaningful results is highlighted.
Export Options
About this article
Cite this article as:
Fares A. Mario, Computational and Statistical Methods to Explore the Various Dimensions of Protein Evolution, Current Bioinformatics 2006; 1 (2) . https://dx.doi.org/10.2174/157489306777011950
DOI https://dx.doi.org/10.2174/157489306777011950 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Tyrosine Kinase Update: Role and Response in Cancer Therapy
Current Cancer Therapy Reviews Natural Naphthoquinones with Great Importance in Medicinal Chemistry
Current Organic Synthesis Salmonella as Live Trojan Horse for Vaccine Development and Cancer Gene Therapy
Current Gene Therapy Identification and Characterization of BRCA1 and BRCA2 Founder Mutations
Current Women`s Health Reviews Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches
Current Pharmaceutical Design Natural Product-Inspired Synthesis of Thiazolidine and Thiazolidinone Compounds and their Anticancer Activities
Current Pharmaceutical Design The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Identification of Phosphoproteins and their Impact as Biomarkers in Cancer Therapeutics
Current Signal Transduction Therapy Prostate Cancer Gene Expression Marker 1 (PCGEM1): A Patented Prostate- Specific Non-Coding Gene and Regulator of Prostate Cancer Progression
Recent Patents on DNA & Gene Sequences Sphingolipid Modulation: A Strategy for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Molecular Chaperone Activity and Biological Regulatory Actions of the TPR-Domain Immunophilins FKBP51 and FKBP52
Current Protein & Peptide Science Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
Current Drug Metabolism